New insight of obesity-associated NAFLD: Dysregulated "crosstalk" between multi-organ and the liver?

被引:18
作者
Wang, Ya-Di [1 ]
Wu, Liang-Liang [2 ]
Qi, Xiao-Yan [1 ]
Wang, Yuan-Yuan [1 ]
Liao, Zhe-Zhen [1 ]
Liu, Jiang-Hua [1 ]
Xiao, Xin-Hua [1 ,3 ]
机构
[1] Univ South China, Affiliated Hosp 1, Hengyang Med Sch, Dept Metab & Endocrinol, Hengyang 421001, Hunan, Peoples R China
[2] Univ South China, Affiliated Hosp 1, Hengyang Med Sch, Dept Gastrointestinal Surg, Hengyang 421001, Hunan, Peoples R China
[3] ChuanShan Rd 69, Hengyang 421001, Hunan, Peoples R China
基金
中国国家自然科学基金;
关键词
Hormones; Non-alcoholic fatty; liver disease (NAFLD); Obesity; Organokines; INDUCED HEPATIC STEATOSIS; BROWN ADIPOSE-TISSUE; DIET-INDUCED OBESITY; INSULIN-RESISTANCE; NONALCOHOLIC STEATOHEPATITIS; GENE-EXPRESSION; EXTRACELLULAR VESICLES; EXOSOMAL MIRNAS; SKELETAL-MUSCLE; DISEASE NAFLD;
D O I
10.1016/j.gendis.2021.12.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Obesity plays a crucial role in the development of non-alcoholic fatty liver disease (NAFLD). However, the underlying mechanism for the pathogenesis of obesity-associated NAFLD remains largely obscure. Although the "multiple hit" theory provides a more accurate explanation of NAFLD pathogenesis, it still cannot fully explain precisely how obesity causes NAFLD. The liver is the key integrator of the body's energy needs, receiving input from multi-ple metabolically active organs. Thus, recent studies have advocated the "multiple crosstalk" hypothesis, highlighting that obesity-related hepatic steatosis may be the result of dysregu-lated "crosstalk" among multiple extra-hepatic organs and the liver in obesity. A wide variety of circulating endocrine hormones work together to orchestrate this "crosstalk". Of note, with deepening understanding of the endocrine system, the perception of hormones has gradually risen from the narrow sense (i.e. traditional hormones) to the broad sense of hormones as or-ganokines and exosomes. In this review, we focus on the perspective of organic endocrine hor-mones (organokines) and molecular endocrine hormones (exosomes), summarizing systematically how the two types of new hormones mediate the dialogue between extra -hepatic organs and liver in the pathogenesis of obesity-related NAFLD. 2022 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons. org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:799 / 812
页数:14
相关论文
共 161 条
[1]   Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration [J].
Alvarez-Sola, Gloria ;
Uriarte, Iker ;
Ujue Latasa, M. ;
Fernandez-Barrena, Maite G. ;
Urtasun, Raquel ;
Elizalde, Maria ;
Barcena-Varela, Marina ;
Jimenez, Maddalen ;
Chang, Haisul C. ;
Barbero, Roberto ;
Catalan, Victoria ;
Rodriguez, Amaia ;
Fruhbeck, Gema ;
Gallego-Escuredo, Jose M. ;
Gavalda-Navarr, Aleix ;
Villarroya, Francesc ;
Rodriguez-Ortigosa, Carlos M. ;
Corrales, Fernando J. ;
Prieto, Jesus ;
Berraondo, Pedro ;
Berasain, Carmen ;
Avila, Matias A. .
GUT, 2017, 66 (10) :1818-1828
[2]   Serum Osteocalcin Levels in Children With Nonalcoholic Fatty Liver Disease [J].
Amin, Saleh ;
El Amrousy, Doaa ;
Elrifaey, Shaymaa ;
Gamal, Rasha ;
Hodeib, Hossam .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2018, 66 (01) :117-121
[3]   Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease [J].
Arab, Juan Pablo ;
Arrese, Marco ;
Trauner, Michael .
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 13, 2018, 13 :321-350
[4]   Myostatin: more than just a regulator of muscle mass [J].
Argiles, Josep M. ;
Orpi, Marcel ;
Busquets, Silvia ;
Lopez-Soriano, Francisco J. .
DRUG DISCOVERY TODAY, 2012, 17 (13-14) :702-709
[5]   Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease [J].
Azzu, Vian ;
Vacca, Michele ;
Virtue, Samuel ;
Allison, Michael E. D. ;
Vidal-Puig, Antonio .
GASTROENTEROLOGY, 2020, 158 (07) :1899-1912
[6]   Adipose may actively delay progression of NAFLD by releasing tumor-suppressing, anti-fibrotic miR-122 into circulation [J].
Baranova, A. ;
Maltseva, D. ;
Tonevitsky, A. .
OBESITY REVIEWS, 2019, 20 (01) :108-118
[7]   β-aminoisobutyric acid prevents diet-induced obesity in mice with partial leptin deficiency [J].
Begriche, Karima ;
Massart, Julie ;
Abbey-Toby, Adje ;
Igoudjil, Anissa ;
Letteon, Philippe ;
Fromenty, Bernard .
OBESITY, 2008, 16 (09) :2053-2067
[8]   Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase [J].
Ben-Shlomo, Shani ;
Zvibel, Isabel ;
Shnell, Mati ;
Shlomai, Amir ;
Chepurko, Elena ;
Halpern, Zamir ;
Barzilai, Nir ;
Oren, Ran ;
Fishman, Sigal .
JOURNAL OF HEPATOLOGY, 2011, 54 (06) :1214-1223
[9]   Elevated Expression of Osteopontin May Be Related to Adipose Tissue Macrophage Accumulation and Liver Steatosis in Morbid Obesity [J].
Bertola, Adeline ;
Deveaux, Vanessa ;
Bonnafous, Stephanie ;
Rousseau, Deborah ;
Anty, Rodolphe ;
Wakkach, Abdelilah ;
Dahman, Moncef ;
Tordjman, Joan ;
Clement, Karine ;
McQuaid, Siobhan E. ;
Frayn, Keith N. ;
Huet, Pierre-Michel ;
Gugenheim, Jean ;
Lotersztajn, Sophie ;
Le Marchand-Brustel, Yannick ;
Tran, Albert ;
Gual, Philippe .
DIABETES, 2009, 58 (01) :125-133
[10]   Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) [J].
Bifari, Francesco ;
Manfrini, Roberto ;
Cas, Michele Dei ;
Berra, Cesare ;
Siano, Matteo ;
Zuin, Massimo ;
Paroni, Rita ;
Folli, Franco .
PHARMACOLOGICAL RESEARCH, 2018, 137 :219-229